AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ZVRA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Zevra Therapeutics, Inc. stock downgraded to Sell Candidate
(Updated on May 20, 2024)

Sell candidate since May 20, 2024 PDF

The Zevra Therapeutics, Inc. stock price fell by -0.85% on the last day (Monday, 20th May 2024) from $4.73 to $4.69. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.78% from a day low at $4.68 to a day high of $4.81. The price has fallen in 7 of the last 10 days and is down by -9.02% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -9 thousand shares and in total, 131 thousand shares were bought and sold for approximately $616.72 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -32.27% during the next 3 months and, with a 90% probability hold a price between $2.48 and $3.37 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ZVRA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 4.22%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zevra Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.79 and $4.79. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Zevra Therapeutics, Inc. stock

Zevra Therapeutics, Inc. finds support from accumulated volume at $4.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.130 between high and low, or 2.78%. For the last week the stock has had daily average volatility of 3.52%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ZVRA) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Zevra Therapeutics, Inc. to open at $4.73, and during the day (based on 14 day Average True Range), to move between $4.47 and $4.91, which gives a possible trading interval of +/-$0.216 (+/-4.60%) up or down from last closing price. If Zevra Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 9.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.58 (2.35%) than the resistance at $4.82 (2.77%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Zevra Therapeutics, Inc. stock A Buy?

Zevra Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.188 Sell Candidate Downgraded

Predicted Opening Price for Zevra Therapeutics, Inc. of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
$4.73 ( 0.782%) $4.69

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ZVRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.86 3.55 %
R2 4.81 2.49 %
R1 4.78 1.84 %
Current price: 4.69
Support S1 4.68 -0.277 %
S2 4.65 -0.93 %
S3 4.60 -1.99 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.16 10.02 %
R2 5.03 7.25 %
R1 4.82 2.77 %
Current price 4.69
Support S1 4.58 -2.35%
S2 4.52 -3.62%
S3 4.50 -4.05%

FAQ

What is the symbol for Zevra Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Zevra Therapeutics, Inc. is ZVRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Zevra Therapeutics, Inc. Stock?
Zevra Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Zevra Therapeutics, Inc. Stock?
Zevra Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zevra Therapeutics, Inc. Stock.

What's the current price of Zevra Therapeutics, Inc. Stock?
As of the end of day on the May 20, 2024, the price of an Zevra Therapeutics, Inc. (ZVRA) share was $4.69.

What is the 52-week high and low for Zevra Therapeutics, Inc. Stock?
The 52-week high for Zevra Therapeutics, Inc. Stock is $7.28 and the 52-week low is $3.89.

What is the market capitalization of Zevra Therapeutics, Inc. Stock?
As of the May 20, 2024, the market capitalization of Zevra Therapeutics, Inc. is 196.293M.

When is the next earnings date for Zevra Therapeutics, Inc.?
The upcoming earnings date for Zevra Therapeutics, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!